老虎證券

BUZZ-Moderna shares fall after birth defect vaccine trial misses target

Reuters
2025/10/23
BUZZ-<a href="https://laohu8.com/S/MRNA">Moderna</a> shares fall after birth defect vaccine trial misses target

** Shares of biotechnology company Moderna MRNA.O down 3.5% to$25.91 premarket after co halts development of birth defect vaccine following trial setback

** Experimental Cytomegalovirus (CMV) vaccine mRNA-1647 showed efficacy of 6% to 23% in 7,500 women, missing company’s target in a last-stage trial

** CMV can cause birth defects if passed from mother to baby during pregnancy; no approved vaccine to cure it currently exists

* MRNA does not expect the trial goal to break even by 2028

**Co does not expect trial failure to impact 2025 outlook

** Four out of 25 analysts rate stock "buy", 16 "hold" and five rate it "sell" or below; median PT at $30.50 - data compiled by LSEG

** As of Wednesday's close, MRNA shares down 35.43% YTD,

(Reporting by Tharuniyaa Lakshmi in Bengaluru)

((tharuniyaa@thomsonreuters.com))

應版權方要求，你需要登入查看該內容

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10